Maria Camila Gonzalez

M.D. and Epidemiologist🇨🇴/🇳🇴 Ph.D. (c) in Health Technology. Admin Officer for the The European-Dementia with Lewy body consortium🧠 #eDLBConsortium

[Centre for Healthy Brain Ageing, KCL @KCL_OAP]

This week @AarslandDag and @mc_gonzalez_MD presented at the International Lewy Body Dementia conference in Amsterdam, sharing progress on their project on the new Neuronal Synuclein Disorder framework in their European DLB cohort.
Read more here:
https://t.co/CeOmm7Bjqz

[Neuroscience Next Argentina @NeuroNextArg]

Meet our #NeuroSpeaker @mcecifer, MD!

🌐 She will be part of Buenos Aires Hub 2025 to present "Prodromal Lewy Body Dementia"

Don't miss her presentation!

Register now:
📎 https://t.co/GhecEGRo4q

#AAIC #Fleni #lewybody #Argentina #dementia #endalz #neurology @LuCrivelliOk

[Maria Camila Gonzalez @mc_gonzalez_MD]

#ADPD24 I was thrilled to share additional findings from the European DLB consortium at this year's ADPD conference. It's a fantastic opportunity to meet the co-authors and showcase these results! #edlbConsortium

[Maria Camila Gonzalez @mc_gonzalez_MD]

We are here 🤓amigos #ADPD2024

[Daniel Ferreira @DrFerreiraD]

Job Opportunity!! We have just opened a postdoc position in my lab. If you want to do neuroimaging research at a very nice scientific environment with multiple opportunities please apply here: https://t.co/Slsw4QXIKK

[Maria Camila Gonzalez @mc_gonzalez_MD]

We had our plenary #edlbconsortium meeting today🧠 our Hub leaders presented their amazing progress and bright future in DLB research. Great start for this #ADPD2024 week

[Maria Camila Gonzalez @mc_gonzalez_MD]

#ADPD has become a cherished ritual.
I'm excited to see dear colleagues, remarkable discoveries, and the great science that lies ahead. Can’t wait to see you all in Lisbon🇵🇹 #ADPD2024 #Lisbon 🧠

[The Nobel Prize @NobelPrize]

“What is important in science is to understand that one should not be too bound to the dogma. You have to be ready for the unexpected.”

- 2020 chemistry laureate Emmanuelle Charpentier, awarded the #NobelPrize “for the development of a method for genome editing.”

[Maria Camila Gonzalez @mc_gonzalez_MD]

@mchaparro13 @ColneColombia @FulbrightCol @CCLRI Bravooooo Mauro✨

[NKB @ParkinsonNKB]

🌟Exceptional reviews for ParkinsonNet Norway at @arendalsuka! 🌟 The future for providing care in #Parkinsons looks promising with our model 🚀 Read more in @DagensMedisin #ParkinsonNetNorway #Arendalsuka #Healthcare

https://t.co/DIOD2DRi2P

[Lewy Body Society @lbsorg]

A reminder of a brilliant day and one of our most important projects to date 💙

#AScarfForLewy

[Nicholas Ashton @NicholasAshton]

Talking to @SelectScience about blood tests for #Alzheimers disease and how @QuanterixSimoa technology has made this possible

[VJDementia @VJDementia]

Carla Abdelnour (@Stanford_Neuro) discusses her study of p-tau181 to identify AD co-pathology in DLB

p-tau181 successfully identified AD co-pathology & predicted those who were likely to decline more quickly over 6 years of follow-up: https://t.co/gXYWbjFWPA

#AAIC23

[Maria Camila Gonzalez @mc_gonzalez_MD]

@nachogenePD @LARGE_PD Amazing group of people!! #proudFVL

[Nacho Mata @nachogenePD]

First @LARGE_PD meeting in the books! It was an in redoble experience , all thanks to this amazing group of people who are compromised with improving things for people with Parkinson’s in Latinoamérica! Proud to be part of this effort! Thank you Cali 🇨🇴

[Joe Kane @jpmkane]

Let's turn Latin America purple @fedrodriguezp @mc_gonzalez_MD @carlaabdelnour @AgustinMIbanez @MiguelGBorda2 🇪🇨🇨🇱🇻🇪🇨🇴🇨🇷🇧🇴🇵🇾🇺🇾🇵🇦🇳🇮🇵🇾🇸🇷🇬����

[Nicholas Ashton @NicholasAshton]

A longitudinal look at preclinical #Alzheimers in blood.
🩸 #pTau181 & #GFAP increase during preclinical AD
🧬#APOE ε4 carriers have faster increase
👩Females show more acceleration in GFAP
🩸#Aβ & #pTau231 are abnormal earlier

Congrats to @YakoubYara
https://t.co/UVwZhctFlM

[NKB @ParkinsonNKB]

Debate persists: are DLB & PDD distinct phenotypes? 🧠 In a study by @mc_gonzalez_MD in @MDCP_Journal, we showed that DLB and PDD patients experienced similar rates of cognitive and motor decline. This is relevant for future clinical trial designs.
https://t.co/hxhvWPKAzD

[Maria Camila Gonzalez @mc_gonzalez_MD]

I'm thrilled with this wonderful news🧠!! Can't wait for #ADPD2024 #Lisbon🇵🇹 next to the talented @carlaabdelnour

[AD/PD - Advances in Science & Therapy @adpdnet]

Time to announce our first winners in the photo contest. Congratulations to @mc_gonzalez_MD and @carlaabdelnour!🤩

Thank you for participating and sharing your #ADPD2023 experience with us!🙏

We are looking forward to seeing you at #ADPD2024 in Lisbon! https://t.co/yP6ZKFrde7

[Maria Camila Gonzalez @mc_gonzalez_MD]

@adpdnet @carlaabdelnour 😁Thank you ADPD!!! See you in Lisbon